Advancing CAR-NK cell therapy in solid tumors: Current landscape and future directions

Cell Reports Medicine · Published 2026-06-25 · DOI 10.1016/j.xcrm.2026.102881

Free full text

Authors (7)

Gohar Shahwar Manzar, Md Faqrul Hasan, Madison Moore, Silvia Tiberti, Nahum Puebla Osorio, Rafet Basar, May Daher

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Manzar, G., Hasan, M., Moore, M., et al. (2026). Advancing CAR-NK cell therapy in solid tumors: Current landscape and future directions. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2026.102881

Related articles

• The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions · Human Vaccines & Immunotherapeutics · 2026 · Cites or is cited by this article
• Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors · Cancer Immunology, Immunotherapy · 2021 · Cites or is cited by this article
• Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models · Cell Reports Medicine · 2026 · Same journal
• Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit · Cell Reports Medicine · 2026 · Same journal
• Persistent cytolytic CD8+ T cells recognize SARS-CoV-2 and herpesvirus epitopes in long COVID · Cell Reports Medicine · 2026 · Same journal
• Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination · Cell Reports Medicine · 2026 · Same journal
• Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment · Cell Reports Medicine · 2026 · Same journal
• Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells · Cell Reports Medicine · 2026 · Same journal
• Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice · Cell Reports Medicine · 2026 · Same journal
• Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy · Cell Reports Medicine · 2026 · Same journal